Incredible news reported by The McCullough Foundation gives hope to cancer patients. Dr. McCullough and Malcolm engage in a very informative talk on these new developments. This episode gets very personal with a recent loss of someone very close to our network, due to the traditional means of radiation and chemotherapy to fight cancer. Perhaps this new treatment can provide other means of fighting this evil disease. There is also Malcolm's upcoming colonoscopy, which highlights the importance of routine checkups and our gut health.
TRUTH LIVES on at https://sgtreport.tv/
NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients - Breast, prostate, and melanoma patients experienced dramatic tumor regression and long-lasting remission -- without chemotherapy.
Fenbendazole (FBZ) is a low-cost veterinary antiparasitic drug that has gained global attention as a potential anticancer therapy. Like ivermectin -- another antiparasitic widely repurposed in research and clinical practice for its potent anti-tumor effects -- fenbendazole appears to work far beyond its original veterinary use.
A newly published case series by Dr. William Makis et al in Case Reports in Oncology presents three remarkable patients with advanced, stage IV cancers (breast, prostate, and melanoma) who self-administered Fenbendazole outside conventional oncology protocols. All three achieved either complete or near-complete remission -- sustained for up to three years -- without chemotherapy:
This is only the second published case series documenting human cancer remissions linked to fenbendazole use. Strikingly, two of the three patients achieved "no evidence of disease" -- a rare outcome in advanced stage IV cancers.
However:
- Patients self-medicated without controlled oversight.
- All used FBZ alongside other treatments, making causality unclear.
- Spontaneous remission, though rare, cannot be excluded.
Still, the consistency across cases -- different cancers, different regimens, same outcome: regression or remission -- signals a phenomenon too important to dismiss.
FBZ is cheap, accessible, and already proven safe in veterinary medicine. What's lacking is rigorous human clinical research. Clinical trials should be immediately initiated to assess fenbendazole's true potential.